BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21709278)

  • 1. Diabetes complications: the microRNA perspective.
    Kantharidis P; Wang B; Carew RM; Lan HY
    Diabetes; 2011 Jul; 60(7):1832-7. PubMed ID: 21709278
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical review: The role of advanced glycation end products in progression and complications of diabetes.
    Goh SY; Cooper ME
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1143-52. PubMed ID: 18182449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway.
    Hagiwara S; McClelland A; Kantharidis P
    J Diabetes Res; 2013; 2013():173783. PubMed ID: 24575418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of diabetes mellitus and diabetes complications.
    Cole JB; Florez JC
    Nat Rev Nephrol; 2020 Jul; 16(7):377-390. PubMed ID: 32398868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of RAGE for attenuating progression of diabetic vascular complications.
    Win MT; Yamamoto Y; Munesue S; Saito H; Han D; Motoyoshi S; Kamal T; Ohara T; Watanabe T; Yamamoto H
    Exp Diabetes Res; 2012; 2012():894605. PubMed ID: 22110482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between polymorphisms G1704T and G82S of RAGE gene and diabetic retinopathy in Japanese type 2 diabetic patients.
    Kashiwagi A; Araki S
    Intern Med; 2005 May; 44(5):397-8. PubMed ID: 15942078
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycemic control and the risk of microvascular complications in people with diabetes mellitus.
    Tasci I; Basgoz BB; Saglam K
    Acta Diabetol; 2016 Feb; 53(1):129-30. PubMed ID: 26063176
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetics of diabetic retinopathy.
    Uhlmann K; Kovacs P; Boettcher Y; Hammes HP; Paschke R
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):275-94. PubMed ID: 16868886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic complication: definition and classification].
    Nishizawa Y
    Nihon Rinsho; 1991 Feb; 49 Suppl():3-8. PubMed ID: 2033818
    [No Abstract]   [Full Text] [Related]  

  • 11. Advanced glycation end products and diabetic complications.
    Stitt AW; Jenkins AJ; Cooper ME
    Expert Opin Investig Drugs; 2002 Sep; 11(9):1205-23. PubMed ID: 12225243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy.
    Kang P; Tian C; Jia C
    Gene; 2012 May; 500(1):1-9. PubMed ID: 22475522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.
    Ramasamy R; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2011 Dec; 1243():88-102. PubMed ID: 22211895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of diabetic nephropathy: a radical approach.
    Salahudeen AK; Kanji V; Reckelhoff JF; Schmidt AM
    Nephrol Dial Transplant; 1997 Apr; 12(4):664-8. PubMed ID: 9140991
    [No Abstract]   [Full Text] [Related]  

  • 15. Advanced glycation end-products: a review.
    Singh R; Barden A; Mori T; Beilin L
    Diabetologia; 2001 Feb; 44(2):129-46. PubMed ID: 11270668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advanced glycosylation end products and chronic complications of diabetes mellitus].
    Méndez JD
    Gac Med Mex; 2003; 139(1):49-55. PubMed ID: 12666409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
    Alouffi S; Khan MWA
    Curr Protein Pept Sci; 2020; 21(9):890-898. PubMed ID: 31660813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into DNA methylation and its critical implications in diabetic vascular complications.
    Zheng J; Cheng J; Zhang Q; Xiao X
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28183874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.
    Ramasamy R; Vannucci SJ; Yan SS; Herold K; Yan SF; Schmidt AM
    Glycobiology; 2005 Jul; 15(7):16R-28R. PubMed ID: 15764591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.